WHO R&D Blueprint consultation: Developing a framework for evaluating new COVID-19 vaccines
The WHO R&D Blueprint is organizing a consultation to discuss emerging evidence towards the establishment of correlates of protection for COVID-19 vaccines.
There is a global need to increase the supply of vaccines that likely meet the WHO target product profile (TPP) criteria for effectiveness against severe disease.
WHO is considering the development of a framework to help evaluate new vaccines, against currently circulating variants or for pan-sarbecovirus vaccines. This may also help inform researchers and developers decisions on how to generate additional data for the assessment of new vaccines.
The scientific elements of the proposed framework will be presented and discussed during this meeting.